Tdap: new option for pertussis booster vaccination of seniors Read more about Tdap: new option for pertussis booster vaccination of seniors31 views
The importance of pertussis in older adults: a growing case for reviewing vaccination strategy in the elderly Read more about The importance of pertussis in older adults: a growing case for reviewing vaccination strategy in the elderly10 views
Increased population prevalence of low pertussis toxin antibody levels in young children preceding a record pertussis epidemic in Australia Read more about Increased population prevalence of low pertussis toxin antibody levels in young children preceding a record pertussis epidemic in Australia24 views
The seroepidemiology of pertussis in NSW: fluctuating immunity profiles related to changes in vaccination schedules Read more about The seroepidemiology of pertussis in NSW: fluctuating immunity profiles related to changes in vaccination schedules4 views
Bug Breakfast in the Bulletin: Pertussis in NSW and its prevention in infants and children Read more about Bug Breakfast in the Bulletin: Pertussis in NSW and its prevention in infants and children4 views
The impact of adolescent pertussis immunization, 2004–2009: lessons from Australia Read more about The impact of adolescent pertussis immunization, 2004–2009: lessons from Australia5 views
Immunogenicity of the reduced-antigen-content dTpa vaccine (Boostrix®) in adults 55 years of age and over: a sub-analysis of four trials Read more about Immunogenicity of the reduced-antigen-content dTpa vaccine (Boostrix®) in adults 55 years of age and over: a sub-analysis of four trials108 views
Severe pertussis in infants: estimated impact of first vaccine dose at 6 versus 8 weeks in Australia Read more about Severe pertussis in infants: estimated impact of first vaccine dose at 6 versus 8 weeks in Australia22 views
A decennial booster dose of reduced antigen content diphtheria, tetanus, acellular pertussis vaccine (Boostrix™) is immunogenic and well tolerated in adults Read more about A decennial booster dose of reduced antigen content diphtheria, tetanus, acellular pertussis vaccine (Boostrix™) is immunogenic and well tolerated in adults157 views
Review of the 2008–2009 pertussis epidemic in NSW: notifications and hospitalisations Read more about Review of the 2008–2009 pertussis epidemic in NSW: notifications and hospitalisations3 views
